Neulasta
information and resources from the National Cancer Institute
Neulasta
(Other name for: pegfilgrastim)Neulasta
(Other name for: pegfilgrastim)
Pegfilgrastim
Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Amgen, Inc Jan 31 2002
|
|
|
|
news articles
Long-Term Study Shows Safety of Neupogen® in AML Treatment Mar 17, 2006
Cancer Consultants (press release), ...patients. Agents such as Neupogen or Neulasta® (pegfilgastrim) are available to stimulate the body to produce more immune cells. ...
Long-Term Study Shows Safety of Neupogen® Support in AML ... Mar 17, 2006
Cancer Consultants (press release), However, this study clearly demonstrates that Neupogen, and by extrapolation the more commonly used Neulasta® (pegfilgrastim), can be used safely in patients ...
Demand to expand Mar 28, 2006
TMCnet Manufacturing also is being expanded at a cost of $1 billion in Puerto Rico to boost capacity for drugs produced there -- Epogen, Aranesp, Neupogen and Neulasta ...
Biotechs take a stronghold on sales Mar 1, 2006
Newark Star Ledger, ...top 20 drugs, including Aranesp for kidney-disease-related and chemotherapy-related anemia; Epogen, for anemia from chronic kidney disease; Neulasta, a white ...
Manhattan Research Reveals Top Ten Consumer-Ranked Pharmaceutical ... Mar 7, 2006
PR Newswire (press release), XR, Herceptin, Humalog, Humira, Humulin, Imitrex, Lamisil, Leukine, Levaquin, Levitra, Lexapro, Lipitor, Lovenox, Lunesta, Nasonex, Neulasta, Neurontin, Nexium ...
The Best-Selling Drugs In America Feb 27, 2006
Forbes According to IMS Health's data, Pfizer makes 3 of the top 20 drugs in the US Amgen makes four of them, including Aranesp, Epogen, Neulasta and Enbrel. ...
Neulasta® and Aranesp® Prevent Adverse Effects of Dose-Dense ... Nov 28, 2005
Cancer Consultants (press release), Treatment with Neulasta® (pegfilgrastim) and Aranesp® (darbepoetin alfa) safely and effectively prevented febrile neutropenia and anemia among women ...
Neulasta® and Aranesp® Provide Effective Hematopoietic Support ... Nov 21, 2005
Cancer Consultants (press release), Researchers from the Dana Farber Cancer Centerhave reported that the prophylactic administration of pegfilgrastim (Neulasta) and darbepoetin alfa (Aranesp) was ...
Amgen initiated with "buy" Dec 16, 2005
New Ratings ...published this morning, the analyst mentions that the performance of Amgen's core business remains robust, driven by the company's Aranesp, Neulasta and Enbrel ...
Tandem High-Dose Chemotherapy Superior to Dose-Dense Chemotherapy ... Dec 5, 2005
Cancer Consultants (press release), ...assures rapid recovery of both neutrophils and platelets while current growth factor therapy with Neupogen® (filgrastim) or Neulasta® (pegfilgrastim) only ...
Long-Term Safety of Dose-Dense Adjuvant Chemotherapy for Breast ... Dec 8, 2005
Cancer Consultants (press release), ...effect of suppressed blood cell production, researchers have administered a granulocyte colony-stimulating factor, such as Neupogen or Neulasta (pegfilgrastim ...
Nektar India launches R&D centre Dec 4, 2005
Sify, ...that used Nektar's drug delivery technologies, Gill said the company has worked on PEG-Inteferon Alpha-2A (Pegasys-Roche) and PEG-filgrastim (Neulasta, Amgen). ...
Amgen "outperform" Dec 1, 2005
New Ratings ...s Aranesp would be boosted by an increasingly binary market, given the company’s competitive leverage from offering Aranesp, Neupogen and Neulasta, and its ...
Nektar India's R&D centre in Hyderabad Dec 4, 2005
Andhra Cafe, ...in biology, engineering and chemistry.The company has worked on products like PEG-Inteferon Alpha-2A (Pegasys-Roche) and PEG-filgrastim (Neulasta, Amgen).
Biotech Earnings Jump In Quarter Nov 21, 2005
Chemical & Engineering News ...$668 million. And combined sales of the infection fighters Neulasta and Neupogen enjoyed a 17% jump to $882 million. In contrast ...
|
|
